The University of Texas Southwestern Medical Center (UT Southwestern) received a $812,957 Project Grant award from the National Human Genome Research Institute (CFDA 93.172 - Human Genome Research) effective January 1, 2025. The grant supports a 5-year research project to "Develop Consensus on a Practical Framework for Variant Reclassification and Recontact" in clinical genetic testing. The project aims to explore stakeholder views, identify underlying principles, and develop expert consensus on policy guidance for addressing the frequent reclassification of genetic variants and the associated need for patient recontact. The goal is to generate a durable framework of principles to guide ongoing policy development as genetic science and knowledge evolves, rather than prescriptive recommendations with limited shelf-life.
Generated 1/28/25, 8:38 AM